Conference Reflects Rising Investor Interest
By Murray W. Wolf
Biotechnology was the focus when healthcare companies, investors and industry VIPs first gathered in 1982 for what was then called the Hambrecht & Quist Life Sciences Conference. Today, the biotech, pharmaceuticals and medical technology sectors continue to dominate this annual event, now known as the JP Morgan Healthcare Conference.
The full content of this article is only available to paid subscribers. If you are an active subscriber, please log in. To subscribe, please click here: SUBSCRIBE
